Results 31 to 40 of about 22,388 (216)
Public health programs in the United States screen more than four million babies each year for at least 30 genetic disorders. The Health and Human Services (HHS) Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC) recommends the ...
Kshea Hale +4 more
doaj +1 more source
Altered electrical properties in skeletal muscle of mice with glycogen storage disease type II
Electrical impedance methods, including electrical impedance myography, are increasingly being used as biomarkers of muscle health since they measure passive electrical properties of muscle that alter in disease.
Janice A. Nagy +4 more
doaj +1 more source
Early diagnosis of lysosomal storage diseases (LSDs) through newborn screening (NBS) has been adapted widely. The National Taiwan University Hospital Newborn Screening Center launched the four-plex tandem mass spectrometry LSD newborn screening test in ...
Shu-Chuan Chiang +7 more
doaj +1 more source
Impact of enzyme replacement therapy on survival in adults with Pompe disease: Results from a prospective international observational study [PDF]
Background: Pompe disease is a rare metabolic myopathy for which disease-specific enzyme replacement therapy (ERT) has been available since 2006. ERT has shown efficacy concerning muscle strength and pulmonary function in adult patients. However, no data
D'Agostino, R.B. (Ralph) +7 more
core +1 more source
Cardiac involvement in adults with Pompe disease [PDF]
Background. Glycogen storage disease type II or Pompe disease is a neuromuscular disorder caused by deficiency of lysosomal acid α- glucosidase. Classic infantile Pompe disease results in massive left ventricular (LV) hypertrophy and failure.
Beek, N.A.M.E. (Nadine) van der +8 more
core +2 more sources
PAS-positive lymphocyte vacuoles can be used as diagnostic screening test for Pompe disease [PDF]
Screening of blood films for the presence of periodic acid-Schiff (PAS)-positive lymphocyte vacuoles is sometimes used to support the diagnosis of Pompe disease, but the actual diagnostic value is still unknown.
Marloes L. C. Hagemans +27 more
core +1 more source
Newborn Screening for Pompe Disease [PDF]
Glycogen storage disease type II (also known as Pompe disease (PD)) is an autosomal recessive disorder caused by defects in α-glucosidase (AαGlu), resulting in lysosomal glycogen accumulation in skeletal and heart muscles. Accumulation and tissue damage rates depend on residual enzyme activity.
Takaaki Sawada +2 more
openaire +3 more sources
Infantile Pompe disease with intrauterine onset: a case report and literature review
Background Pompe disease is a rare autosomal recessive disease. Acid alpha−glucosidase (GAA) deficiency leads to glycogen storage in lysosomes, causing skeletal, cardiac, and smooth muscle lesions.
Hongmin Xi +5 more
doaj +1 more source
Background: The genetic prevalence of Pompe disease was estimated based on the proportion of individuals who have a causative genotype in a general population database.
Kyung Sun Park
doaj +1 more source
Analysis of ischaemic crisis using the informational causal entropy-complexity plane [PDF]
In the present work, an ischaemic process, mainly focused on the reperfusion stage, is studied using the informational causal entropy-complexity plane.
Francisco O. Redelico +8 more
core +1 more source

